Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors
暂无分享,去创建一个
J. Geigl | F. Moinfar | B. Liegl-Atzwanger | E. Heitzer | Peter Ulz | F. Tavassoli | O. Saglam | M. Devouassoux-Shisheboran | Karin Flicker | Stephanie M Müller
[1] F. Guyon,et al. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions , 2015, Modern Pathology.
[2] D. N. Markowski,et al. Cytogenetically normal uterine leiomyomas without MED12-mutations – a source to identify unknown mechanisms of the development of uterine smooth muscle tumors , 2014, Molecular Cytogenetics.
[3] Haiyang Guo,et al. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma , 2014, Cancer.
[4] E. Oliva,et al. Uterine Leiomyomas With Bizarre Nuclei: A Clinicopathologic Study of 59 Cases , 2014, The American journal of surgical pathology.
[5] S. Croce,et al. Intracystic papillary carcinoma of the breast: a diagnostic challenge with major clinical impact. , 2014, Anticancer research.
[6] L. Aaltonen,et al. Genomics of uterine leiomyomas: insights from high-throughput sequencing. , 2014, Fertility and sterility.
[7] Jian-jun Wei,et al. MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma , 2014, Modern Pathology.
[8] R. Kurman,et al. WHO classification of tumours of female reproductive organs , 2014 .
[9] L. Aaltonen,et al. Chromothripsis in uterine leiomyomas. , 2013, The New England journal of medicine.
[10] L. Aaltonen,et al. Characterization of uterine leiomyomas by whole-genome sequencing. , 2013, The New England journal of medicine.
[11] J. Fletcher,et al. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma , 2013, Modern Pathology.
[12] K. Hunt,et al. Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience , 2013, Annals of Surgical Oncology.
[13] F. Moinfar,et al. Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases , 2012, BMC Genomics.
[14] Christopher C. Holmes,et al. GREVE: Genomic Recurrent Event ViEwer to assist the identification of patterns across individual cancer samples , 2012, Bioinform..
[15] F. Chibon,et al. MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors , 2012, PloS one.
[16] L. Aaltonen,et al. MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas , 2011, Science.
[17] J. Dermody,et al. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas , 2009, Modern Pathology.
[18] P. Clement,et al. Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP):: A Clinicopathologic Analysis of 16 Cases , 2009, The American journal of surgical pathology.
[19] K. Hunt,et al. Genetic aberrations in soft tissue leiomyosarcoma. , 2009, Cancer letters.
[20] P. Pandolfi,et al. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas , 2007, Nature Medicine.
[21] J. Fletcher,et al. Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications , 2007, The American journal of surgical pathology.
[22] C. Toon,et al. Myxoid symplastic leiomyoma of the uterus. , 2006, Pathology.
[23] P. Cin,et al. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features , 2006, Genes, chromosomes & cancer.
[24] P. Nederlof,et al. A multiplex PCR predictor for aCGH success of FFPE samples , 2005, British Journal of Cancer.
[25] U. Surti,et al. Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. , 2005, Cancer genetics and cytogenetics.
[26] C. Walker,et al. Uterine Fibroids: The Elephant in the Room , 2005, Science.
[27] Shuanzeng Wei,et al. Uterine adenomyoma with lymphoid infiltration simulating lymphoma. , 2004, Gynecologic oncology.
[28] P. Cin,et al. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling , 2004, Genes, chromosomes & cancer.
[29] M. Zhan,et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. , 2004, Gynecologic oncology.
[30] Kuan-Hui Huang,et al. Multiple uterine angioleiomyomas in a woman presenting with severe menorrhagia. , 2003, Gynecologic oncology.
[31] Peter Devilee,et al. Pathology and Genetics of Tumours of the Breast and Female Genital Organs , 2003 .
[32] E. Harlow,et al. The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.
[33] C. Morton,et al. Leiomyomata: heritability and cytogenetic studies. , 2001, Human reproduction update.
[34] A. Kaider,et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. , 1999, Gynecologic oncology.
[35] B. Quade,et al. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. , 1999, The American journal of pathology.
[36] C. Villena-Heinsen,et al. Leiomyosarcomas of the female genital tract: a clinical and histopathological study. , 1998, European journal of gynaecological oncology.
[37] B. Helpap,et al. [Uterine leiomyosarcoma with subsequent pregnancy]. , 1998, Zentralblatt fur Gynakologie.
[38] A. Berchuck,et al. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization , 1997, Molecular carcinogenesis.
[39] S. Thoresen,et al. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. , 1997, European journal of cancer.
[40] M. Shintaku. Iipoleiomyomatous tumors of the uterus: A heterogeneous group? Histopathological study of five cases , 1996, Pathology international.
[41] R. Prayson,et al. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls. , 1996, The American journal of surgical pathology.
[42] P. Clement,et al. Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. , 1995, The American journal of surgical pathology.
[43] J. Sklar,et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata , 1994, Genes, chromosomes & cancer.
[44] R. Kempson,et al. Problematic Uterine Smooth Muscle Neoplasms: A Clinicopathologic Study of 213 Cases , 1994, The American journal of surgical pathology.
[45] A. Sandberg,et al. Chromosomal abnormalities in leiomyosarcomas. , 1993, The American journal of pathology.
[46] P. Clement,et al. Diffuse, Perinodular, and Other Patterns of Hydropic Degeneration Within and Adjacent to Uterine Leiomyomas: Problems in Differential Diagnosis , 1992, The American journal of surgical pathology.
[47] J. Fletcher,et al. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. , 1990, Cancer research.
[48] N. Harris,et al. Uterine Leiomyomas with Lymphoid Infiltration Simulating Lymphoma. A Report of Seven Cases , 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[49] N. Weiss,et al. The epidemiology of sarcomas of the uterus. , 1986, Journal of the National Cancer Institute.
[50] J. Myles,et al. Apoplectic leiomyomas of the uterus: A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage , 1985, The American journal of surgical pathology.
[51] S. Gisser,et al. Neurilemoma-like uterine myomas: an ultrastructural reaffirmation of their non-Schwannian nature. , 1977, American journal of obstetrics and gynecology.
[52] R. Kurman,et al. Mesenchymal tumors of the uterus VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear‐cell leiomyoma. A clinical and pathologic analysis of 26 cases , 1976, Cancer.